Rossini M, Di Munno O, Valentini G, Bianchi G, Biasi G, Cacace E, Malesci D, La Montagna G, Viapiana O, Adami S
PA requires a documented T2D diagnosis and evidence of metformin step-therapy (or documented intolerance/contraindication)
It is not insulin
However, the findings provide encouraging evidence that injectable semaglutide may emerge as a promising therapeutic option for women with PMOS seeking improvements in both metabolic and reproductive health.
When interpreted correctly, the OAT can reveal root causes and empower families to make targeted, evidence-informed changes
Mediterranean diet-based interventions to improve anthropometric and obesity indicators in children and adolescents: a systematic review with meta-analysis of randomized controlled trials